BCM
GWPH

Brookstone Capital Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Brookstone Capital Management’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,220
Closed -$210K – 489
2019
Q2 		$210K Buy
+1,220
New +$211K 0.01% 408
2015
Q4 		– Sell
-50
Closed -$5K – 963
2015
Q3 		$5K Buy
+50
New +$5.56K ﹤0.01% 1417

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Brookstone Capital Management's GWPH Position: Q3 2019 in Review

Brookstone Capital Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q3 2019, closing a stake of 1,220 shares — an estimated $210K sold.

Brookstone Capital Management first reported a position in GWPH in Q3 2015 and held it in 2 quarters. The position peaked at $210K in Q2 2019. 316 funds tracked by Wall St. Rank hold GWPH as of Q3 2019.

  • Brookstone Capital Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q3 2019 after selling out during the quarter.
  • Brookstone Capital Management sold 1,220 GW Pharmaceuticals Plc American Depositary Shares shares in Q3 2019, an estimated $210K.
  • Brookstone Capital Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2015 and held it in 2 quarters.
  • Brookstone Capital Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $210K in Q2 2019.
  • 316 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2019.

Based on Brookstone Capital Management's 13F filing for Q3 2019, filed 18 Oct 2019.